Mundelein, IL, United States of America

Pamela L Donner

USPTO Granted Patents = 26 

 

 

Average Co-Inventor Count = 15.2

ph-index = 8

Forward Citations = 229(Granted Patents)


Company Filing History:


Years Active: 2010-2018

Loading Chart...
Loading Chart...
Loading Chart...
26 patents (USPTO):

Title: Innovator Spotlight: Pamela L Donner - Pioneering Anti-Viral Compounds Inventor

Introduction:

Pamela L Donner, a notable inventor based in Mundelein, IL (US), has made significant contributions to the field of antiviral compounds. With a remarkable portfolio of 26 patents, Donner has been at the forefront of innovative solutions in inhibiting the replication of the Hepatitis C virus (HCV).

Latest Patents:

Donner's latest patents focus on describing compounds that effectively inhibit the replication of the HCV. These inventions also encompass processes for producing such compounds, compositions containing them, and methods for utilizing these compounds in the treatment of HCV infections.

Career Highlights:

Throughout her career, Pamela L Donner has been associated with esteemed companies such as AbbVie Inc. and Abbott Laboratories Corporation. Her dedication to research and development has led to groundbreaking discoveries in the pharmaceutical industry, particularly in the realm of antiviral treatments.

Collaborations:

Donner has collaborated with notable peers in the field, including Allan C Krueger and David A DeGoey. These collaborations have synergistically contributed to the advancement of innovative antiviral technologies, further solidifying Donner's reputation as a pioneering inventor.

Conclusion:

In conclusion, Pamela L Donner's relentless pursuit of innovation in antiviral compounds has not only resulted in a substantial patent portfolio but has also significantly impacted the medical field's ability to combat HCV infections. Her invaluable contributions exemplify the essence of ingenuity and dedication in the realm of pharmaceutical inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…